PsyLabs

Cape Town, South Africa Founded: 2021 • Age: 5 yrs
Pharmaceutical-grade psychedelics are supplied for research and clinical trials.
Request Access

About PsyLabs

PsyLabs is a company based in Cape Town (South Africa) founded in 2021.. PsyLabs has raised $4 million across 2 funding rounds from investors including Psyence Biomed. PsyLabs offers products and services including Psilocybin Extracts, Active Pharmaceutical Ingredients, and Functional Mushroom Products. PsyLabs operates in a competitive market with competitors including AmerisourceBergen, Activo Health, Brunel, Rand Pharmaceutical Distributors and Anmarate, among others.

  • Headquarter Cape Town, South Africa
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $4 M (USD)

    in 2 rounds

  • Latest Funding Round
    $3.5 M (USD), Series A

    Aug 15, 2025

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of PsyLabs

PsyLabs offers a comprehensive portfolio of products and services, including Psilocybin Extracts, Active Pharmaceutical Ingredients, and Functional Mushroom Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Extracted psychedelic substances for research and medical applications

Purified APIs with regulatory dossiers for clinical trials

Non-psychoactive adaptogens for stress relief and general health

Funding Insights of PsyLabs

PsyLabs has successfully raised a total of $4M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $3.5 million completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series A — $3.5M
  • First Round

    (15 Apr 2025)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2025 Amount Series A - PsyLabs Valuation Psyence Biomed
Apr, 2025 Amount Seed - PsyLabs Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in PsyLabs

PsyLabs has secured backing from 1 investor. Prominent investors backing the company include Psyence Biomed. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Psilocybin-based psychedelic medicines are developed for therapeutic applications.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by PsyLabs

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - PsyLabs

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Psylabs Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of PsyLabs

PsyLabs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Activo Health, Brunel, Rand Pharmaceutical Distributors and Anmarate, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Pharmaceutical distribution and supply chain services are provided globally.
domain founded_year HQ Location
Pharmaceutical products are distributed by Activo Health in South Africa.
domain founded_year HQ Location
Diversified drugs are distributed by Brunel in South Africa.
domain founded_year HQ Location
Pharmaceutical products are distributed in South Africa by the company.
domain founded_year HQ Location
R&D company focused on manufacturing of drugs for multiple therapeutic areas
domain founded_year HQ Location
Distributor of pharmaceutical products
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Psylabs

Frequently Asked Questions about PsyLabs

When was PsyLabs founded?

PsyLabs was founded in 2021 and raised its 1st funding round 4 years after it was founded.

Where is PsyLabs located?

PsyLabs is headquartered in Cape Town, South Africa. It is registered at Cape Town, Western Cape, South Africa.

Is PsyLabs a funded company?

PsyLabs is a funded company, having raised a total of $4M across 2 funding rounds to date. The company's 1st funding round was a Seed of $500K, raised on Apr 15, 2025.

What does PsyLabs do?

Licensed supplier of pharmaceutical-grade psychedelics for research and clinical trials. It operates licensed cultivation and extraction facilities, producing quality-assured psychedelic substances. The company develops purified APIs with associated Drug Master Files and Technical documents, ready for Investigative New Drug applications. A proprietary extraction and refinement process is used, with patents filed to protect this methodology. The company also offers a range of functional mushroom wellness products. Regulatory support, including export permits and Certificates of Analysis, accompanies all products.

Who are the top competitors of PsyLabs?

PsyLabs's top competitors include AmerisourceBergen, Activo Health and Brunel.

What products or services does PsyLabs offer?

PsyLabs offers Psilocybin Extracts, Active Pharmaceutical Ingredients, and Functional Mushroom Products.

Who are PsyLabs's investors?

PsyLabs has 1 investor. Key investors include Psyence Biomed.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available